Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'138 -0.8%  SPI 12'988 -0.8%  Dow 29'684 1.9%  DAX 12'008 -1.4%  Euro 0.9537 0.4%  EStoxx50 3'290 -1.4%  Gold 1'656 -0.3%  Bitcoin 18'949 -0.2%  Dollar 0.9809 0.5%  Öl 90.0 0.8% 

Aktionärsstruktur

Inhaber in %
Freefloat 93.71
BlackRock Fund Advisors 3.23
Nomura Asset NEXT FUNDS TOPIX ETF (1306) 3.21
Nippon Life Insurance Co. 2.01
Nikko Asset Listed Index TOPIX ETF (1308) 1.49
Daiwa Asset TOPIX Listed ETF (1305) 1.47
BlackRock Japan Co., Ltd. 1.47
Government Pension Fund - Global (The) 1.45
Takeda Pharmaceutical Co., Ltd. 1.35
Vanguard Total International Stock Index Fund 1.26
Takeda Science Foundation 1.13
Takeda Pharmaceutical Employee Long Term Incentive Plan 0.76

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020 2021 2022
Personal am Ende des Jahres 29'900 27'230 49'578 47'495 47'099 47'347
Umsatz pro Mitarbeiter in Mio. EUR 57.93 65.02 42.30 69.30 67.90 75.38

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020 2021 2022
Summe Umlaufvermögen 1'260'662 1'078'808 3'050'658 2'469'432 2'712'893 2'593'642
Summe Anlagevermögen 3'097'962 3'036'235 11'089'944 10'186'246 10'244'820 10'493'668
Summe Aktiva 4'355'782 4'106'463 13'872'322 12'821'094 12'912'293 13'178'018

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020 2021 2022
Gesamtverschuldung/ -verbindlichkeiten 1'203'701 1'038'811 5'930'362 5'462'763 5'071'783 4'810'649
Summe Fremdkapital 2'406'818 2'089'054 8'708'734 8'093'608 7'735'116 7'494'496
Summe Eigenkapital 1'948'965 2'017'409 5'163'588 4'727'486 5'177'177 5'683'523
Summe Passiva 4'355'783 4'106'463 13'872'322 12'821'094 12'912'293 13'178'019

Adresse

4-1-1 Dosho-machi, 540-8645 Osaka
Telefon +81 (6) 6204-2111
Fax +81 (6) 6204-2880
URL http://www.takeda.co.jp

Management

Andrew S. Plump
Director, President-Research & Development
Christophe Weber
President, CEO & Representative Director
Christopher David O'Reilly
Global Head-Investor Relations
Constantine Saroukos
Chief Financial Officer & Director
Emiko Higashi
Independent Outside Director
Giles Platford
President-Europe & Canada
Haruhiko Hirate
Corporate Communications & Public Affairs Officer
Ian T. Clark
Independent Outside Director
Jean-Luc Butel
Independent Outside Director
John M. Maraganore
Independent Outside Director
Julie So-Young Kim
President-Plasma-Derived Therapies
Kimberly A. Reed
Independent Outside Director
Koji Hatsukawa
Independent Outside Director
Marcello Agosti
Head-Global Commercial Organization
Masami Iijima
Chairman
Masato Iwasaki
Representative Director & Head-Japan
Michael E. Mendelsohn
Chief Medical & Scientific Officer
Michel Orsinger
Independent Outside Director
Mikuno Furuta
Corporate Strategy Officer & Chief of Staff
Mwana Lugogo
Chief Ethics Officer
Norimasa Takeda
Chief Accounting Officer & Corporate Controller
Olivier Jean Bohuon
Independent Non-Executive Outside Director
Padma Thiruvengadam
Chief Human Resources Officer
Ramy Riad
CFO-Global Plasma Derived Therapies
Ricardo Marek
President-Growth & Emerging Markets Business Unit
Rupa Cornell
Vice President-Legal
Salvatore Alesci
Head-R & D Global Science & Biomedical Policy
Satoru Takemoto
General Manager-Sales
Steven H. Gillis
Independent Outside Director
Takashi Okubo
Global Head-Investor Relations & Global Finance
Yoshiaki Fujimori
Independent Outside Director
Yoshihiro Nakagawa
Executive Officer & Global General Counsel

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen